Head Shop 'Legal Highs' Active Constituents Identification Chart

Head Shop 'Legal Highs' Active Constituents Identification Chart

Head Shop ‘Legal Highs’ Active Constituents Identification Chart (May 2010, pre-‘511’) •Mephedrone •Mephedrone •Mephedrone •Mephedrone •Methylone •Methylone •Methylone (66.1% as HCl salt, (82.2% as HCl salt, (14.6% as HCl salt, (39.9% as HCl salt, 54.8% as free base) 68.1% as free base ) 12.1% as free base) 33.1% as free base) •Caffeine •Benzocaine •Benzocaine •Methylone •Mephedrone •Flephedrone •Flephedrone •MDPV •Caffeine •MDPV •Lignocaine •Lignocaine •Dimethylamylamine (DMAA) •Caffeine •Caffeine Pack 1 Pack 2 •Flephedrone •MDPV •MDPV •MDPV •Butylone •Butylone •Lignocaine •Lignocaine •Lignocaine •A s ign ifican t amoun t o f w ha t is be lieve d •MDPV •Caffeine to be an isomer of butylone was also found. •p-Fluorophenylpiperazine •Butylone •m-Trifluoromethylphenylpiperazine •Caffeine •Butylone •Dimethylamylamine (DMAA) (pPFP) •CffiCaffeine (mTFMPP) •2-Phenylethylamine (2-PEA) •Caffeine •Caffeine •Hordenine •Caffeine •Methylone •m-TiflTrifluorome thlhthylpheny lilpiperaz ine •MhdMephedrone •2-AiAmino idindane (2-AI, •MDPV (mTFMPP) 2-indanamine) •1-Methyl-4-benzylpiperazine (Methyl BZP) •Caffeine •Caffeine •m-Trifluoromethylphenylpiperazine •Caffeine •Butylone •Butylone (mTFMPP) •MDPV •Mephedrone •p-Fluorophenylpiperazine (pPFP) •Caffeine •Butylone •Mephedrone •2-Phenylethylamine (2-PEA) •Caffeine •Dimethylamylamine (DMAA) •Lignocaine •Dimethylamylamine (DMAA) •Dimethylamylamine (DMAA) •Caffeine These are the active constituents that we have found to date in the above products. It may be expected that Next Generation Compounds (NGC's) (i.e. new pharmacologically active compounds) will be used as active constituents in the above products following the banning of a number cathinone and piperazine derivatives on May 11, 2010 (www.dohc.ie/press/releases/2010/20100511.html). Recently NAPHYRONE has emerged as a replacement for mephedrone. If you have any questions please contact us - [email protected] Pierce Kavanagh1, Sinead McNamara2, Daniel Angelov1, Sean McDermott1, Daniel Mullan1 and Sheila Ryder3 1 Department of Pharmacology and Therapeutics, School of Medicine, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8. 2 Drug Treatment Centre Board, Pearse Street, Dublin 2. 3 School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin 2..

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us